Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - VidaMed (US) president and Chief Executive Officer to resign:

This article was originally published in Clinica

Executive Summary

James Heisch is to resign as president and CEO of VidaMed, a US manufacturer of advanced systems for the treatment of urological conditions. Mr Heisch said it was now time for VidaMed to recruit a seasoned medical-device executive who would lead the company in the launch of its transurethral ablation system (TUNA) for the treatment of benign prostatic hyperplasia. The system is already FDA-approved.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080714

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel